Marc Boutin, VP & COO, Discusses Comparative Effectiveness Research and Drug Safety

Sunday, September 19, 2010

 BioCentury This Week features NHC Executive Vice President and COO Marc Boutin commenting on comparative effectiveness research and drug safety.